Topigen Pharmaceuticals Inc.'s President And CEO To Present At Dow Jones VentureWire Health Care Innovations Conference

MONTREAL and PARSIPPANY, NJ -- (MARKET WIRE) -- September 07, 2006 -- TOPIGEN Pharmaceuticals, Inc., an emerging biopharmaceutical company specializing in developing treatments for respiratory diseases, today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will be presenting at the "Health Care Innovations 2006: Finding and Funding the Cures of Tomorrow" Conference produced by Dow Jones VentureWire daily newsletter. The conference will take place at the Sofitel San Francisco Bay in Redwood City, California from September 12-13, 2006. Dr. Wotton's presentation will take place on Tuesday, September 12th from 12:50-1:05 pm PDT, and he will be available for one-on-one meetings during the conference.
MORE ON THIS TOPIC